MENU
ATOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Atossa Therapeutics (ATOS) Ownership - Who owns Atossa Therapeutics?
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
87.11M
P/E Ratio
N/A
Total Cash
74.77M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash/Share
0.58
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATOS
Capitalization
87.1M
P/E Ratio
N/A
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash
74.8M
Total Cash/Share
0.58
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
73.7M
P/B Ratio
1.18
Cash Flow
N/A
Earnings
-0.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22.9M
Current Ratio
13.30
Current Revenue Per Employee
25741.47
Dividends Per Share - Security
N/A
EBITDA
-29.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.42
Revenue To Assets
-29.71
Shares Held By Institutions
46M
Shares Outstanding - Current
129M
Total Liabilities
5.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-28.726
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of products for breast cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com